NanoGuardian hires ex-FBI, pharma specialist

Staff writer

19-Jan-2009

Picture of Doctor John Glover US anti-counterfeiting technology company NanoGuardian has appointed Dr. John Glover as the head of its Security Advisory Board.

Glover worked for more than 35 years with the US Federal Bureau of Investigation (FBI), before taking up the role of vice president, corporate security, at Bristol-Myers Squibb. He was a a key figure in setting up the Pharmaceutical Security Institute and also served as co-chairman of the US State Department's Overseas Security Advisory Council.

In a statement, NanoGuardian said that Glover "will advise NanoGuardian in its efforts to curb the spread of counterfeit and diverted pharmaceuticals in the supply chain."

NanoGuardian's NanoEncryption technology consists of layered overt, covert and forensic security features that can be applied directly to tablets, capsules and vial caps.

Features
Showcase
Research
Events

Wellcome Trust backs counterfeit drug analysis project
The Wellcome Trust has awarded £473,000 ($737,000) in funding to researchers in the UK and Sweden to create a low-cost instrument that can screen medicines for quality and authenticity.
Start-up aims to make pharma cargo tamper-proof
A security system to protect cargo containers and pallets from theft and tampering is promising to improve security in the pharmaceutical sector.
Brazil may swap its serialisation scheme for Turkish model
Brazil may back away from its current plans for a national serialisation system for drugs and adopt one closer to the Turkish model.